Abu Dhabi has become the first place globally to deliver ITVISMA gene therapy for spinal muscular atrophy, marking a major healthcare milestone and reinforcing the emirate's role as a leader in genomics, precision medicine, and advanced treatments.
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) in eligible adults and children aged two years and above.
New Delhi [India], December 9: Miltenyi Biotec has been honoured with the Special Recognition Award for Pioneering Work in Cell & Gene Therapy at the BioSpectrum India Excellence Awards 2025, held on 5th December at the India Habitat Centre in Delhi. The award acknowledges the company's pion
Mumbai (Maharashtra) [India], December 2: ImmunoAdoptive Cell Therapy (ImmunoACT), the Mumbai, India-based pioneering research and cell and gene therapy development company, announced a strategic partnership with Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI compa
Mumbai (Maharashtra) [India], November 27: LipidVerse 2025, a landmark one-day conference dedicated to exploring cutting-edge advancements in lipid-based technologies for pharmaceutical applications, successfully concluded at the Indian Institute of Technology Bombay (IIT Bombay). The event
Over two days, the Forum welcomed more than 2,500 participants, over 200 speakers, and representatives of more than 100 global institutions, reinforcing its position as the world's largest gathering of futurists. DFF also announced that the next edition of the Forum will be held on 17-18 Nov
The findings, published this week in the peer-reviewed journal Nature Neuroscience, identify a previously unknown molecular mechanism that drives ALS and demonstrate a potential RNA-based gene therapy capable of stopping nerve degeneration and even regenerating damaged nerve cells.
Nucelion Therapeutics Pvt Ltd, a newly established Hyderabad-based Contract Research, Development, and Manufacturing Organisation (CRDMO) focused on cell and gene therapies, announced its formal launch on Monday.
Israeli and US scientists have developed a promising new gene therapy that could one day restore hearing and balance for millions of people with genetic inner ear disorders.
Kolkata (West Bengal) [India], June 25: In a heartening milestone for pediatric care and collective compassion, baby Aasmika Das from West Bengal has successfully undergone Zolgensma gene therapy at a leading hospital in Kolkata.
Mumbai (Maharashtra) [India], June 19: In a significant step toward strengthening India's leadership in cutting-edge biotherapeutics, Miltenyi Biotec India Private Limited and the Biotechnology Industry Research Assistance Council (BIRAC) signed a strategic Letter of Intent (LOI) at the BIO
This facility ushers in a new era of gene and cell therapies to tackle scientific challenges such as targeted gene expression, immune system modulation, and long-term cell survival. The work will span from boosting immune responses against cancer to ensuring that therapeutic proteins are saf